INTERVENTIONAL STRATEGY FOR CLINICALLY SIGNIFICANT THROMBOSIS OF THE SUPERIOR VENA CAVA AND BRACHIOCEPHALIC VEIN

Cover Page

Abstract


Superior vena cava syndrome (SVCS) is a relatively common complication of malignant mediastinal tumors and can cause severe functional impairment. Over the past 20 years, in addition to the conventional management of the disease, interventional treatment of this syndrome has become a viable option for alleviating the symptoms of SVCS. Thus, multidisciplinary care can maximize the effectiveness of treatment for patients with SVCS.


About the authors

A E Vasiliev

FGBU Research Center for Hematology, Moscow, Russia

Author for correspondence.
Email: atnlu88@mail.ru

O V Margolin

FGBU Research Center for Hematology, Moscow, Russia

Email: konovalov_oe@rudn.university

S R Karagyulyan

FGBU Research Center for Hematology, Moscow, Russia

Email: konovalov_oe@rudn.university

D A Rogov

FGBU Research Center for Hematology, Moscow, Russia

Email: konovalov_oe@rudn.university

D G Gitelzon

FGBU Research Center for Hematology, Moscow, Russia

Email: konovalov_oe@rudn.university

M A Vasiliev

RUDN University, Moscow, Russia

Email: konovalov_oe@rudn.university

E A Gitelzon

RUDN University, Moscow, Russia

Email: konovalov_oe@rudn.university

References

  1. Hunter W. & Johnston W. The history of an aneurysm of the aorta, with some remarks on aneu-rysms in general. London: William Johnston; 1757.
  2. Christopher Straka, James Ying, Feng-Ming Kong, Christopher D. Willey, Joseph Kaminski, & D.W. Nathan Kim. Review of evolving etiologies, implications and treatment strategies for the su-perior vena cava syndrome. Springerplus. 2016; 5: 229.
  3. Mohammed S. Al-Natour, Pouya Entezami, Munier M.S. Nazzal, Casabianca A.B., Ragheb As-saly, Kalen Riley & Daniel Gaudin. Superior vena cava syndrome with retropharyngeal edema as a complication of ventriculoatrial shunt. Clinical Case Reports. 2015; 3(10): 777—780.
  4. Schechter M.M. The superior vena cava syndrome. Am. J. Med. Sci. 1954. 227:46—56.
  5. Flounders J. Superior vena cava syndrome. Oncol Nurs Forum. 2003. 30(4):E84—8.
  6. Hassikou H. Bono W., Bahiri R. et al. Vascularinvolvement in Behcet’s disease. Two case reports. Joint bone spine. 2002 June. 69(4):416—8.
  7. Rice T.W., Rodriguez R.M., Light R.W. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore). 2006 Jan; 85(1):37—42.
  8. Marcy P.Y., Magne N., Bentolila F., et al. Superior vena cava obstruction: is stenting necessary? Support Care Cancer. 2001 Mar. 9(2):103—7.
  9. Akoglu H., Yilmaz R., Peynircioglu B., et al. A rare complicationof hemodialysis catheters: supe-rior vena cava syndrome. Hemodial Int. 2007 Oct.11(4):385—91.
  10. Wan J.F., Bezjak A. Superior vena cava syndrome. Hematol Oncol Clin North Am. 2010 Jun; 24(3):501—13.

Statistics

Views

Abstract - 323

PDF (Russian) - 132

Cited-By


PlumX

Dimensions


Copyright (c) 2017 Vasiliev A.E., Margolin O.V., Karagyulyan S.R., Rogov D.A., Gitelzon D.G., Vasiliev M.A., Gitelzon E.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies